MUNTONI, Elisabetta
MUNTONI, Elisabetta
SCIENZA E TECNOLOGIA DEL FARMACO
A new apomorphine formulation for oral administration
2007-01-01 Zara GP; Cattaldo S; Cavalli R; Calderoni S; Muntoni E; Gasco MR; Mauro A; Eandi M
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines
2005-01-01 Serpe L; Cavalli R; Guido M; Canaparo R; Muntoni E; Gasco MR; Mauro A; Eandi M; Zara GP
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines
2005-01-01 Serpe L; Cavalli R; Canaparo R; Muntoni E; Gasco MR; Eandi M; Zara GP
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data
2003-01-01 CASALE F; COSTA M; CANAPARO R; MUNTONI E; DELLA PEPA C; BERNO E; ZARA GP; PASERO E; EANDI M
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract
2005-01-01 Canaparo R; Nordmark A; Finnstrom N; Lundgren S; Seidegard J; Jeppsson B; Serpe L; Muntoni E; Eandi M; Zara GP; Rane A
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line
2003-01-01 Serpe L; Catalano MG; Cavalli R; Ugazio E; Muntoni E; Canaparo R; Muntoni E; Frairia R; Gasco MR; Zara GP; Eandi M
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype
2005-01-01 Canaparo R; Serpe L; Calvo PL; Barbera C; Muntoni E; Eandi M; Zara GP
Enhanced oral bioavailability of resveratrol using lipid formulations
2012-01-01 Argenziano, M.; Spagnolo, R.; Muntoni, E.; Zara, G.; Trotta, M.; Cavalli, R.
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug.
2015-01-01 Biasibetti E; Valazza A; Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Panciani PP; Riganti C; Annovazzi L; Caldera V; Schiffer D; Lanotte M; Capucchio M.T.
GIFC-2018 - BOOK OF ABSTRACTS
2018-01-01 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients
2000-01-01 Canaparo R; Muntoni E; Serpe L; Della Pepa C; Zara GP; Casale F; Eandi M
Impact of age in phenothype of thiopurine methyltransferase
2008-01-01 Calvo PL; Canaparo R; Baldi M; Serpe L; Giaccone M; Lerro P; Muntoni E; D’Antico S; Vinciguerra T; Eandi M; Zara GP; Barbera C
Macromolecules in Drug Delivery
2017-01-01 Ahmadi Nahid, Marini Elisabetta, Muntoni Elisabetta, Milla Paola, Battaglia Luigi
Methotrexate loaded SLN obtained by coacervation for potential glioblastoma treatment
2014-01-01 L. Battaglia; M. Gallarate; E. Peira; D. Chirio; L. Gastaldi; E. Muntoni; E. Biasibetti; M.T. Capucchio; A. Valazza; P. Panciani; M. Lanotte; D. Schiffer; L. Annovazzi; V. Caldera; C. Riganti
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles
2005-01-01 Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M
Ophthalmic delivery of dexamethsone and tobramycin incorporated in solid lipid nanoparticles
2005-01-01 Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M
Paclitaxel incorporato in nanoparticelle lipidiche solide: studio preliminare farmacocinetico e distribuzione cerebrale
2001-01-01 Zara GP; Cavalli R; Serpe L; Ugazio E; Muntoni E; Gasco MR; Eandi M
Pharmacokinetic and pharmacodynamic of dexamethasone - butyrate loaded solid lipid nanoparticles
2012-01-01 E. Imbalzano; E. Muntoni; L. Serpe; F. Foglietta; R. Canaparo; P. Gasco; G.P. Zara
Pharmacokinetics and brain biodistribution of apomorphinne incorporated in solid lipid nanoparticles
2009-01-01 Zara GP; Serpe L; Muntoni E; Gasco MR; Eandi M; Mauro A
Pharmacokinetics and tolerability profile of three new formulations of disodium clodronate after single intramuscular injection in healthy volunteers
2001-01-01 Della Pepa C; Muntoni E; Serpe L; Casale F; Pradelli L; Romano P; Eandi M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A new apomorphine formulation for oral administration | 2007 | Zara GP; Cattaldo S; Cavalli R; Calderoni S; Muntoni E; Gasco MR; Mauro A; Eandi M | |
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines | 2005 | Serpe L; Cavalli R; Guido M; Canaparo R; Muntoni E; Gasco MR; Mauro A; Eandi M; Zara GP | |
Accumulation and cytotoxic activity of different doxorubicin formulations in human cancer cell lines | 2005 | Serpe L; Cavalli R; Canaparo R; Muntoni E; Gasco MR; Eandi M; Zara GP | |
Application of Parzaen-based probabilistic neural networks to predict individual plasma concentration from population data | 2003 | CASALE F; COSTA M; CANAPARO R; MUNTONI E; DELLA PEPA C; BERNO E; ZARA GP; PASERO E; EANDI M | |
CYP3A and MDR1 (P-glycoprotein) gene expression levels along the human gastrointestinal tract | 2005 | Canaparo R; Nordmark A; Finnstrom N; Lundgren S; Seidegard J; Jeppsson B; Serpe L; Muntoni E; Eandi M; Zara GP; Rane A | |
Cytotoxicity of solid lipid nanoparticles incorporating butyric acid and doxorubicin on a human colorectal cancer cell line | 2003 | Serpe L; Catalano MG; Cavalli R; Ugazio E; Muntoni E; Canaparo R; Muntoni E; Frairia R; Gasco MR; Zara GP; Eandi M | |
Differences between Italian children and adults in thiopurine methyltransferase phenotype and genotype | 2005 | Canaparo R; Serpe L; Calvo PL; Barbera C; Muntoni E; Eandi M; Zara GP | |
Enhanced oral bioavailability of resveratrol using lipid formulations | 2012 | Argenziano, M.; Spagnolo, R.; Muntoni, E.; Zara, G.; Trotta, M.; Cavalli, R. | |
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug. | 2015 | Biasibetti E; Valazza A; Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Panciani PP; Riganti C; Annovazzi L; Caldera V; Schiffer D; Lanotte M; Capucchio M.T. | |
GIFC-2018 - BOOK OF ABSTRACTS | 2018 | muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k | |
HPLC determination of 5-FU and three metabolites in the plasma of cancer patients | 2000 | Canaparo R; Muntoni E; Serpe L; Della Pepa C; Zara GP; Casale F; Eandi M | |
Impact of age in phenothype of thiopurine methyltransferase | 2008 | Calvo PL; Canaparo R; Baldi M; Serpe L; Giaccone M; Lerro P; Muntoni E; D’Antico S; Vinciguerra T; Eandi M; Zara GP; Barbera C | |
Macromolecules in Drug Delivery | 2017 | Ahmadi Nahid, Marini Elisabetta, Muntoni Elisabetta, Milla Paola, Battaglia Luigi | |
Methotrexate loaded SLN obtained by coacervation for potential glioblastoma treatment | 2014 | L. Battaglia; M. Gallarate; E. Peira; D. Chirio; L. Gastaldi; E. Muntoni; E. Biasibetti; M.T. Capucchio; A. Valazza; P. Panciani; M. Lanotte; D. Schiffer; L. Annovazzi; V. Caldera; C. Riganti | |
Ophthalmic delivery of dexamethasone and tobramycin incorporated in solid lipid nanoparticles | 2005 | Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M | |
Ophthalmic delivery of dexamethsone and tobramycin incorporated in solid lipid nanoparticles | 2005 | Zara GP; Cavalli R; Canaparo R; Serpe L; Muntoni E; Gasco MR; Eandi M | |
Paclitaxel incorporato in nanoparticelle lipidiche solide: studio preliminare farmacocinetico e distribuzione cerebrale | 2001 | Zara GP; Cavalli R; Serpe L; Ugazio E; Muntoni E; Gasco MR; Eandi M | |
Pharmacokinetic and pharmacodynamic of dexamethasone - butyrate loaded solid lipid nanoparticles | 2012 | E. Imbalzano; E. Muntoni; L. Serpe; F. Foglietta; R. Canaparo; P. Gasco; G.P. Zara | |
Pharmacokinetics and brain biodistribution of apomorphinne incorporated in solid lipid nanoparticles | 2009 | Zara GP; Serpe L; Muntoni E; Gasco MR; Eandi M; Mauro A | |
Pharmacokinetics and tolerability profile of three new formulations of disodium clodronate after single intramuscular injection in healthy volunteers | 2001 | Della Pepa C; Muntoni E; Serpe L; Casale F; Pradelli L; Romano P; Eandi M |